Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): Major implications for genetic counselling

Human Genetics

Volumn 108, Issue 4, 2001, Pages 290-298

  Le Marechal C ^b   Audrezet M P ^b   Quere I ^b   Raguenes O ^c   Langonne S ^c   Ferec C ^c  

^a Laboratoire de Genetique Moleculaire   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DNA DENATURATION; DNA POLYMORPHISM; DNA SEQUENCE; EUROPE; FRANCE; GEL ELECTROPHORESIS; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION PAIR CHROMATOGRAPHY; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN;

ALLELES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXONS; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MUTATION; POLYMORPHISM, GENETIC; TIME FACTORS;

EID: 0035020939     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390100490     Document Type: Article

References (44)

1. Identification of three novel cystic fibrosis mutations in a sample of Italian cystic fibrosis patients
2. Identification of three novel mutations (457 TAT→G, D192G, Q685X) in the Slovenian CF patients
3. Mutation detection using fluorescent enzyme mismatch cleavage with T4 endonuclease VII
4. Mutations in the cystic fibrosis gene in men with congenital bilateral absence of the vas deferents
5. Complete identification of cystic fibrosis transmembrane conductance regulator mutations in the CF population of Saguenay Lac St Jean (Quebec, Canada)
6. Introduction to PCR/OLA/SCS, a multiplex DNA test, and its applications to cystic fibrosis
7. High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes
8. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
9. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
10. Slowly but surely towards better scanning for mutations
11. Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations
12. Simultaneous screening for 11 mutations in the cystic fibrosis transmembrane conductance regulator gene by multiplex amplification and reverse dot-blot
13. Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: Report of a large European external quality assessment
14. "Touchdown" PCR to circumvent spurious priming during gene amplification
15. Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: A cystic fibrosis mutation of Slavic origin common in Central and East Europe
16. Abnormal distribution of CF F508 allele in azoospermic men with congenital aplasia of the epididymis and vas deferens
17. A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning
18. Complexity in a monogenic disease
19. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European population
20. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene
21. Detection of over 98% cystic fibrosis mutations in a Celtic population
22. CFTR gene mutations in adults with disseminated bronchiectasis
23. Screening practices for mutations in the CFTR gene ABCC7
24. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC
25. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations
26. Detection of single nucleotide polymorphisms with the WAVE DNA fragment analysis system
27. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis
28. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations
29. Detection of more than 94% cystic fibrosis mutations in a sample of Belgian population and identification of four novel mutations
30. Detection of CFTR mutations in patients of Native American Indian origin using denaturing gradient gel electrophoresis and DNA sequencing
31. Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients
32. Uniparenteral inheritance of microsatellite alleles of the cystic fibrosis gene (CFTR): Identification of a 50 kilobase deletion
33. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection
34. Comparative DNA sequencing by denaturing high-performance liquid chromatography
35. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC)
36. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
37. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis
38. Neonatal screening for cystic fibrosis in Brittany, France: Assessment of 10 years' experience and impact on prenatal diagnosis
39. Mutations in the cystic fibrosis gene in patients with chronic pancreatitis
40. Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: A report from the Cystic Fibrosis Genetic Analysis Consortium
41. A pre-Columbian Y chromosome-specific transition and its amplications for human evolutionary history
42. Complete screening of mutations in the coding sequence of the CFTR gene in a sample of CF patients from Russia: Identification of three novel alleles
43. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
44. Cystic fibrosis